Alpha Alert: Utilization of Transdermal Clonidine for Refractory Agitation

References

• Giovannitti JA, Thoms SM, Crawford JJ. Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesth Prog. 2015;62(1):31–8. doi:10.2344/0003-3006-62.1.31.
   PubMedGoogle Scholar
• Sabetkasaie M, Vala S, Khansefid N, Hosseini AR, Sadat Ladgevardi MAR. Clonidine and guanfacine-induced antinociception in visceral pain: possible role of alpha 2/I2 binding sites. Eur J Pharmacol. 2004;501(1–3):95–101. doi:10.1016/j.ejphar.2004.08.010.
   PubMed Web of Science ®Google Scholar
• Stollings JL, Kotfis K, Chanques G, Pun BT, Pandharipande PP, Ely EW. Delirium in critical illness: clinical manifestations, outcomes, and management. Intensive Care Med. 2021;47(10):1089–103. doi:10.1007/s00134-021-06503-1.
   PubMed Web of Science ®Google Scholar
• Gagnon DJ, Fontaine GV, Riker RR, Fraser GL. Repurposing valproate, enteral clonidine, and phenobarbital for comfort in adult ICU patients: a literature review with practical considerations. Pharmacotherapy. 2017;37(10):1309–21. doi:10.1002/phar.2017.
   PubMed Web of Science ®Google Scholar
• Gagnon DJ, Riker RR, Glisic EK, Kelner A, Perrey HM, Fraser GL. Transition from dexmedetomidine to enteral clonidine for ICU sedation: an observational pilot study. Pharmacotherapy. 2015;35(3):251–9. doi:10.1002/phar.1559.
   PubMed Web of Science ®Google Scholar
• Clonidine: Drug information - UpToDate. Accessed June 15, 2023. https://www.uptodate.com/contents/clonidine-drug-information?search=clonidine&source=panel_search_result&selectedTitle=1∼148&usage_type=panel&kp_tab=drug_general&display_rank=1.
   Google Scholar
• Purivatra E, Guenette M, Coleman B, Cheung A, Burry L. High-versus low-dose clonidine for sedation and analgesia in critically ill adults: a retrospective cohort study. J Clin Pharm Ther. 2021;46(6):1706–13. doi:10.1111/jcpt.13523.
   PubMed Web of Science ®Google Scholar
• Rupp H, Maisch B, Brilla CG. Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine. Cardiovasc Drug Ther. 1996;10(S1):251–62. doi:10.1007/BF00120495.
   PubMedGoogle Scholar
• Kumar A, Gupta A, Dwivedi Y, Singh TK, Srivastava U, Sarkar ME, Agarwal A, Badada V. Comparison of clonidine and dexmedetomidine for short-term sedation of intensive care unit patients. Indian J Crit Care Med. 2014;18(7):431–6. doi:10.4103/0972-5229.136071.
   PubMedGoogle Scholar
• Wolf A, McKay A, Spowart C, Granville H, Boland A, Petrou S, Sutherland A, Gamble C. Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: the SLEEPS (Safety profiLe, Efficacy and Equivalence in Paediatric intensive care Sedation) study. Health Technol Assess. 2014;18(71):1–212. doi:10.3310/hta18710.
   PubMedGoogle Scholar
• By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052–81. doi:10.1111/jgs.18372.
   PubMed Web of Science ®Google Scholar
• Soares LGL, Naylor C, Martins MA, Peixoto G. Dexmedetomidine: a new option for intractable distress in the dying [4]. J Pain Symptom Manage. 2002;24(1):6–8. doi:10.1016/S0885-3924(02)00423-2.
   PubMed Web of Science ®Google Scholar
• Thomas B, Lo WSA, Nangati Z, Barclay G. Dexmedetomidine for hyperactive delirium at the end of life: an open-label single arm pilot study with dose escalation in adult patients admitted to an inpatient palliative care unit. Palliat Med. 2021;35(4):729–37. doi:10.1177/0269216321994440.
   PubMed Web of Science ®Google Scholar
• Howard P, Curtin J. Efficacy and safety of subcutaneous clonidine for refractory symptoms in palliative medicine: a retrospective study. BMJ Support Palliat Care. 2023;13:e820–824. doi:10.1136/spcare-2022-003651.
   Web of Science ®Google Scholar
• Jiang S, Hernandez M, Burke H, Spurling B, Czuma R, Varghese R, Cohen A, Hartney K, Sullivan G, Kozel FA, et al. A retrospective analysis of guanfacine for the pharmacological management of delirium. Cureus. 2023;15(1):e33393. doi:10.7759/cureus.33393.
   PubMed Web of Science ®Google Scholar
• Palakshappa JA, Hough CL. How we prevent and treat delirium in the ICU. Chest. 2021;160(4):1326–34. doi:10.1016/j.chest.2021.06.002.
   PubMed Web of Science ®Google Scholar
• Subramaniam B, Shankar P, Shaefi S, Mueller A, O’Gara B, Banner-Goodspeed V, Gallagher J, Gasangwa D, Patxot M, Packiasabapathy S, et al. Effect of intravenous acetaminophen vs placebo combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery: the DEXACET randomized clinical trial. JAMA. 2019;321(7):686–96. doi:10.1001/jama.2019.0234.
   PubMed Web of Science ®Google Scholar
• Skrobik Y, Duprey MS, Hill NS, Devlin JW. Low-dose nocturnal dexmedetomidine prevents ICU delirium. a randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2018;197(9):1147–56. doi:10.1164/rccm.201710-1995OC.
   PubMed Web of Science ®Google Scholar
• Su X, Meng Z-T, Wu X-H, Cui F, Li H-L, Wang D-X, Zhu X, Zhu S-N, Maze M, Ma D, et al. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet. 2016;388(10054):1893–902. doi:10.1016/S0140-6736(16)30580-3.
   PubMed Web of Science ®Google Scholar
• Terry K, Blum R, Szumita P. Evaluating the transition from dexmedetomidine to clonidine for agitation management in the intensive care unit. SAGE Open Med. 2015;3:205031211562176. doi:10.1177/2050312115621767.
   Google Scholar
• Capino AC, Miller JL, Johnson PN. Clonidine for sedation and analgesia and withdrawal in critically ill infants and children. Pharmacotherapy. 2016;36(12):1290–9. doi:10.1002/phar.1850.
   PubMed Web of Science ®Google Scholar
• Ye L, Lippmann S. Reduction of anxiety after treatment with transdermal clonidine. American Journal of Health-System Pharmacy. 2018;75(11):742–4. doi:10.2146/ajhp180064.
   PubMed Web of Science ®Google Scholar
• Neerland BE, Busund R, Haaverstad R, Helbostad JL, Landsverk SA, Martinaityte I, Norum HM, Ræder J, Selbaek G, Simpson MR, et al. Alpha-2-adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): protocol for a multicentre randomised controlled trial. BMJ Open. 2022;12(6):e057460. doi:10.1136/bmjopen-2021-057460.
   PubMed Web of Science ®Google Scholar
• Effects of Dexmedetomidine on Delirium Duration of Non-intubated ICU Patients (4D Trial) - Full Text View. ClinicalTrials.gov. Accessed June 15, 2023. https://clinicaltrials.gov/ct2/show/NCT03317067.
   Google Scholar
• Preskorn SH, Zeller S, Citrome L, Finman J, Goldberg JF, Fava M, Kakar R, De Vivo M, Yocca FD, Risinger R, et al. Effect of sublingual dexmedetomidine vs placebo on acute agitation associated with bipolar disorder: a randomized clinical trial. JAMA. 2022;327(8):727–36. doi:10.1001/jama.2022.0799.
   PubMed Web of Science ®Google Scholar